VM202

hepatocyte growth factor gene therapy · Helixmith Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for VM202, covering 2022-08-22 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of VM202 in Painful Diabetic Peripheral Neuropathy -The HOPES Trial [Phase 2]